Poor-prognosis germ cell tumors: we have not yet crossed the finish line
- PMID: 17235039
- DOI: 10.1200/JCO.2006.07.6380
Poor-prognosis germ cell tumors: we have not yet crossed the finish line
Comment on
-
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.J Clin Oncol. 2007 Jan 20;25(3):247-56. doi: 10.1200/JCO.2005.05.4528. J Clin Oncol. 2007. PMID: 17235042 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
